R&G PharmaStudies Co (SZSE:301333) Gross-Profit-to-Asset % : 12.54% (As of Mar. 2024)

R&G PharmaStudies Co Gross-Profit-to-Asset % Chart

R&G PharmaStudies Co Annual Data
	Trend	Dec13	Dec14	Dec15	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Gross-Profit-to-Asset %		Get a 7-Day Free Trial					109.41	38.68	38.42	18.35	14.51

R&G PharmaStudies Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															12.32	17.66	12.41	15.88	12.54

Competitive Comparison of R&G PharmaStudies Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, R&G PharmaStudies Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

R&G PharmaStudies Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, R&G PharmaStudies Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where R&G PharmaStudies Co's Gross-Profit-to-Asset % falls into.

R&G PharmaStudies Co Gross-Profit-to-Asset % Calculation

R&G PharmaStudies Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

R&G PharmaStudies Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

R&G PharmaStudies Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of R&G PharmaStudies Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

R&G PharmaStudies Co (SZSE:301333) Business Description